ICAM-1 targeted catalase encapsulated PLGA-b-PEG nanoparticles against vascular oxidative stress

References

• Ambati J, Lopez AM, Cochran D, Wattamwar P, Bean K, Dziubla TD, Rankin SE. Engineered silica nanocarriers as a high-payload delivery vehicle for antioxidant enzymes. Acta Biomater, 2012;8:2096–103
   PubMed Web of Science ®Google Scholar
• Baran ET, Ozer N, Hasirci V. Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: An in vitro study. J Microencapsul, 2002;19:363–76
   PubMed Web of Science ®Google Scholar
• Beers RF, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem, 1952;195:133–40
   PubMed Web of Science ®Google Scholar
• Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 2007;28:869–76
   PubMed Web of Science ®Google Scholar
• Chorny M, Hood E, Levy RJ, Muzykantov VR. Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles. J Control Release, 2010;146:144–51
   PubMed Web of Science ®Google Scholar
• Dziubla TD, Karim A, Muzykantov VR. Polymer nanocarriers protecting active enzyme cargo against proteolysis. J Control Release, 2005;102:427–39
   PubMed Web of Science ®Google Scholar
• Dziubla TD, Shuvaev VV, Hong NK, Hawkins BJ, Madesh M, Takano H, Simone E, Nakada MT, Fisher A, Albelda SM, Muzykantov VR. Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. Biomaterials, 2008;29:215–27
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Maeda H. Factors and mechanism of “EPR” effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. Adv Exp Med Biol, 2003;519:29–49
   PubMed Web of Science ®Google Scholar
• Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: Novel tools give (free) radical insight. J Mol Cell Cardiol, 2009;47:372–81
   PubMed Web of Science ®Google Scholar
• Garnacho C, Dhami R, Simone E, Dziubla T, Leferovich J, Schuchman EH, Muzykantov VR, Muro S. Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J Pharmacol Exp Ther, 2008;325:400–8
   PubMed Web of Science ®Google Scholar
• Giovagnoli S, Blasi P, Ricci M, Rossi C. Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery. AAPS PharmSciTech, 2004;5:1–9
   Web of Science ®Google Scholar
• Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials, 2011;32:8010–20
   PubMed Web of Science ®Google Scholar
• Hood ED, Chorny M, Greineder CF, Alferiev IS, Levy RJ, Muzykantov VR. Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation. Biomaterials, 2014;35:3708–15
   PubMed Web of Science ®Google Scholar
• Klibanov AM. Enzyme stabilization by ımmobilization. Anal Biochem, 1979;93:1–25
   PubMed Web of Science ®Google Scholar
• Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: A concise review. Nanomedicine, 2005;1:193–212
   PubMed Web of Science ®Google Scholar
• Lee ES, Park KH, Park IS, Na K. Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle. Int J Pharm, 2007;338:310–16
   PubMed Web of Science ®Google Scholar
• Liu CW, Lin WJ. Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin. Int J Nanomedicine, 2012;7:4749–67
   PubMed Web of Science ®Google Scholar
• Loscalzo J. Oxidant stress: A key determinant of atherothrombosis. Biochem Soc Trans, 2003;31:1059–61
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Davis SS. Innovations in avoiding particle clearance from blood by kupffer cells – Cause for reflection. Crit Rev Ther Drug Carrier Syst, 1994;11:31–59
   PubMed Web of Science ®Google Scholar
• Morlock M, Koll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): Protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm, 1997;43:29–36
   Web of Science ®Google Scholar
• Muro S, Garnacho C, Champion JA, Leferovich J, Gajewski C, Schuchman EH, Mitragotri S, Muzykantov VR. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther, 2008;16:1450–8
   PubMed Web of Science ®Google Scholar
• Paulo CSO, Das Neves RP, Ferreira LS. Nanoparticles for intracellular-targeted drug delivery. Nanotechnology, 2011;22:494002
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol, 1998;56:359–84
   PubMed Web of Science ®Google Scholar
• Rojas A, Figueroa H, Re L, Morales MA. Oxidative stress at the vascular wall. Mechanistic and pharmacological aspects. Arch Med Res, 2006;37:436–48
   PubMed Web of Science ®Google Scholar
• Sah H. Protein instability toward organic solvent/water emulsification: Implications for protein microencapsulation into microspheres. PDA J Pharm Sci Technol, 1999;53:3–10
   PubMedGoogle Scholar
• Simone E, Dziubla T, Shuvaev V, Muzykantov VR. Synthesis and characterization of polymer nanocarriers for the targeted delivery of therapeutic enzymes. Methods Mol Biol, 2010;610:145–64
   PubMedGoogle Scholar
• Simone EA, Dziubla TD, Arguiri E, Vardon V, Shuvaev VV, Christofidou-Solomidou M, Muzykantov VR. Loading PEG-catalase into filamentous and spherical polymer nanocarriers. Pharm Res, 2009;26:250–60
   PubMed Web of Science ®Google Scholar
• Spencer JPE, Schroeter H, Kuhnle G, Srai SK, Tyrrell RM, Hahn U, Rice-Evans C. Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J, 2001;354:493–500
   PubMed Web of Science ®Google Scholar
• Şimşek S, Eroğlu H, Kurum B, Ulubayram K. Brain targeting of atorvastatin loaded amphiphilic PLGA-b-PEG nanoparticles. J Microencapsul, 2013;30:10–20
   PubMed Web of Science ®Google Scholar
• Van de Weert M, Hoechstetter J, Hennink WE, Crommelin DJ. The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release, 2000;68:351–9
   PubMed Web of Science ®Google Scholar
• Wadsworth RM. Oxidative stress and the endothelium. Exp Physiol, 2008;93:155–7
   PubMed Web of Science ®Google Scholar
• Wolf M, Wirth M, Pittner F, Gabor F. Stabilisation and determination of the biological activity of L-asparaginase in poly(d,l-lactide-co-glycolide) nanospheres. Int J Pharm, 2003;256:141–52
   PubMed Web of Science ®Google Scholar
• Ye ML, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release, 2010;146:241–60
   PubMed Web of Science ®Google Scholar